A new experimental drug allowed children and adolescents to consume small amounts of peanuts without suffering a serious reaction during a recent study, a California-based pharmaceutical company announced Sunday.
The drug, produced by Aimmune Therapeutics, contains peanut protein. It could help protect people who are allergic to the legume from the sometimes deadly repercussions of accidentally consuming peanut protein.
The product has not yet been approved by the Food and Drug Administration, but could ultimately help a growing part of the U.S. population.
Read more at The Hill.